“The Ministry of Health has stayed the suspension of our manufacturing licence for the drug by the Drug Controller General of India (DCGI). So, we will start production and launch it soon,” Mr Bhaskara Narayana, Chief Financial Officer, Natco Pharma, told Business Line.via Advertisements
Natco Pharma Ltd to re-launch breast cancer drug
Natco Pharma Ltd will re-launch its breast cancer drug, Albupax, in the domestic and global markets soon. Natco Pharma had stopped the production, distribution and marketing of the drug in July 2009 on the instructions of the DCGI which said the drug might cause liver damage.
“The Ministry of Health has stayed the suspension of our manufacturing licence for the drug by the Drug Controller General of India (DCGI). So, we will start production and launch it soon,” Mr Bhaskara Narayana, Chief Financial Officer, Natco Pharma, told Business Line.via Advertisements
“The Ministry of Health has stayed the suspension of our manufacturing licence for the drug by the Drug Controller General of India (DCGI). So, we will start production and launch it soon,” Mr Bhaskara Narayana, Chief Financial Officer, Natco Pharma, told Business Line.via Advertisements
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment